FdaApplication
ANDA 213014
Identifiers
- fda_app_no: ANDA213014
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2021-05-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SILDENAFIL CITRATE | SILDENAFIL CITRATE | EQ 10MG BASE/ML | FOR SUSPENSION;ORAL |
1 product